Sign In
Buy VTRS
$16.39
+0.120 (+0.738%)
At Close: Jul 13, 2026
Viatris gets FDA approval of first biosimilar version of Sanofi's insulin Lantus
08:12am, Thursday, 29'th Jul 2021
Shares of Viatris Inc. gained 3.3% in premarket trading on Thursday, the day after the Food and Drug Administration approved the first biosimilar verson of insulin glargine from Viatris and Biocon Bio
Viatris Stock Gains After FDA Approves Viatris-Biocon Biologics' Insulin Glargine Biosimilar Injection
08:04am, Thursday, 29'th Jul 2021
The FDA cleared Viatris inc (NASDAQ: VTRS) - Biocon Biologics' Semglee insulin glargine-yfgn injection as a biosimilar. Semglee indicates controlling high blood sugar in adults with type 2 diabetes
PITTSBURGH and BENGALURU, India, July 28, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) and Biocon Biologics Ltd. (a subsidiary of Biocon Ltd.
The Real Value Of Viatris Stock
12:23pm, Tuesday, 27'th Jul 2021
The Real Value Of Viatris Stock
Mylan Wins Dismissal of Kansas EpiPen® Direct Purchaser Case
07:30am, Tuesday, 27'th Jul 2021
PITTSBURGH, July 27, 2021 /PRNewswire/ -- Viatris (NASDAQ: VTRS) today announced that the U.S. District Court for the District of Kansas granted Mylan's motion to dismiss in a lawsuit brought against
Bert's Dividend Stock Watch List: July 2021
03:14pm, Thursday, 15'th Jul 2021
The S&P 500 continues to hit record highs. At the time of this article, the S&P 500 finished at nearly 4,375.
My Oh My, 3 Very Strong Buys
07:22pm, Monday, 12'th Jul 2021
The market is 31% historically overvalued, meaning future returns for index investors are likely to be very disappointing, about 4.5% over the next five years. But even in market bubbles, anti-bubble
Viatris Inc. to Release Second Quarter 2021 Financial Results on Aug. 9, 2021
01:59pm, Thursday, 08'th Jul 2021
PITTSBURGH, July 8, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) plans to release its second quarter 2021 financial results on Monday, Aug. 9, before the open of the U.S. financial markets. Chief
Dividend Income Summary: Lanny's June 2021 Summary
11:24am, Monday, 05'th Jul 2021
Dividend Income Summary: Lanny's June 2021 Summary
Viatris: Buy Signals Are So Strong It's Hard To Ignore
04:03pm, Wednesday, 30'th Jun 2021
Viatris: Buy Signals Are So Strong It's Hard To Ignore
Dividend Stock Watch List: Lanny's July 2021 Edition
02:40pm, Wednesday, 30'th Jun 2021
Pfizer hasn't had their price move really this year.
Mylan Wins Significant Summary Judgment Rulings in Kansas EpiPen® Class Action
08:23pm, Wednesday, 23'rd Jun 2021
PITTSBURGH, June 23, 2021 /PRNewswire/ -- Viatris (NASDAQ: VTRS) today announced that the U.S. District Court for the District of Kansas ruled, in substantial part, in Mylan's favor on the company's
3 Absurdly Cheap Stocks to Buy in a Ridiculously Expensive Market
05:55am, Friday, 11'th Jun 2021
And all three of them pay solid dividends.
Viatris Inc. (VTRS) Management Presents at Goldman Sachs 42nd Annual Global Healthcare Conference (Transcript)
05:10pm, Thursday, 10'th Jun 2021
Viatris Inc. (VTRS) Management Presents at Goldman Sachs 42nd Annual Global Healthcare Conference (Transcript)
3 Dividend Stocks Wall Street Thinks Will Soar 20% or More
05:52am, Thursday, 10'th Jun 2021
Attractive dividends plus strong growth? Yes, please.
